Cancer

Article	Citations
Indeterminate pulmonary nodules in non‐rhabdomyosarcoma soft tissue sarcoma: A study of the European paediatric Soft Tissue Sarcoma Study Group	1320
Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors	227
Issue Information	177
A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center	156
Modeled residual current cancer risk after clinical investigation of a positive multicancer early detection test result	127
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer	106
Measuring the impact of a catchment area surveillance tool on cancer center adopters	105
Impact of obesity on outcome in children diagnosed with cancer in Canada: A report from Cancer in Young People in Canada	102
Pathogenic germline variants in patients with endometrial cancer of diverse ancestry	98
	97
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study	92
Effect of a 1‐year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors—A randomized controlled trial (SURfit)	91
Annual report to the nation on the status of cancer, part 1: National cancer statistics	88
An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report	86
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors	85
Incidence, risk factors, and management of alpelisib‐associated hyperglycemia in metastatic breast cancer	74
Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study	63
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532	63
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study	56
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan	55
Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model	55
Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial	53
Risk of suicide among individuals with a history of childhood cancer	53
Oncology patients' perception of physicians who use an integrated electronic health record (EHR) during clinic visits: PRIME‐EHR double‐blind, randomized controlled trial	47
Intersecting identities and cancer screening	45

Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”	45
Issue Information	44
Evaluating educational interventions to increase breast density awareness among Latinas: A randomized trial in a Federally Qualified Health Center	44
Pediatric inflammatory bowel disease increases cancer risk	44
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study	43
Management recommendations for pancreatic manifestations of von Hippel–Lindau disease	43
Issue Information	42
Lower risk of depression after smoking cessation and alcohol abstinence in patients with gastric cancer who underwent gastrectomy: A population‐based, nationwide cohort study	41
More social determinants lead to more cancer death: A tragic dose response	41
New standard of care for multiple myeloma?	40
Neurologic complications of breast cancer	40
Altering the microbiome for immunotherapy‐resistant urological tumors—An intriguing but still early concept	40
Issue Information	40
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?	39
First person profile: Mary‐Ellen Taplin, MD	39
MRI‐guided radiotherapy results in fewer toxicities for localized prostate cancer	39
Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials	38
Withdrawal: “Assessment of prognostic understanding, perceived goals of care, and quality of life in hospitalized patients with leukemia or multiple myeloma” Olivia S. Allen, Nina Kim, Jose Morillo, C	38
Frequency and clinical associations of common mental disorders in adults with high‐grade glioma—A multicenter study	38
Talazoparib for newly diagnosed prostate cancer associated with significant risk reduction of disease progression	38
Long‐term follow‐up of a phase 2 study of all‐trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia	37
Federal Cervical Cancer Collaborative: Improving cervical cancer prevention through vaccination, screening, and management in safety‐net settings of care	37
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single‐arm, phase 2 trial	37
Agreement of medical record abstraction and self‐report of breast cancer treatment with an extended recall window	36
Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy	36
Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta‐analysis	36
Cost and activity analysis for a citywide patient navigation intervention to engage underserved patients in breast cancer treatment: Findings from the Translating Research Into Practice study	35
The Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer (CISTO) study: Lessons learned about management and patient enrollment in a large, pragmatic, patient‐centere	35
Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion	35
Erratum to “Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study”	35
Gender equity in oncology: Progress, challenges, and the path forward in urologic oncology and oncologic specialties	34
Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare	33
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma	33
Association between visceral adiposity index and cancer risk in the UK Biobank cohort	33
Prevalence of carotid ultrasound screening in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study	33
The impact of a small‐group mammography video discussion on promoting screening uptake among nonadherent Chinese American immigrant women: A randomized controlled trial	32
Implantable cardioverter defibrillators in people dying with cancer: A SEER‐Medicare analysis of ICD prevalence and association with aggressive end‐of‐life care	32
Midlife baseline prostate‐specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality	32
Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuva	32
Issue Information	31
	31
New first‐line treatment improves progression‐free survival for select men with bone mCRPC	31
Issue Information	31
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases	31
Reply to COVID‐19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors	31
First person profile: Richard Pazdur, MD	30
Temporal changes in the probability of live birth among female survivors of childhood cancer: A population‐based Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study in five nordic countrie	30
Racism and health among cancer survivors	30
The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup	30
Cost effectiveness of treatment strategies for high risk prostate cancer	30

Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer	30
von Hippel–Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement	30
Evaluation of headache in patients with cancer	30
Making progress against rare cancers: A case study on neuroendocrine tumors	29
An ounce of prevention: Medicaid's role in reducing the burden of cancer in men with HIV	29
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer	29
Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study	29
Industry engagement: Accelerating discovery, application, and adoption through industry partnerships	29
Challenges in clinical trials for high‐risk but curable prostate cancer	28
Fine‐tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic‐phase chronic myeloid leukemia: The choice of the right TKI for the right patient	28
Person‐centered communication about weight and weight management: Focus group discussions in a diverse sample of women with nonmetastatic breast cancer and obesity	28
A real‐world observation on thrombopoietic agents for patients with cancer treatment–induced thrombocytopenia in China: A multicenter, cross‐sectional study	28
Individual‐ and neighborhood‐level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California	27
Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials	27
Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting	27
Circulating tumor DNA in head and neck cancer: Early successes and future promise	27
Issue Information	26
Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis	26
The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome	26
Durable efficacy with fixed‐duration BTKi and venetoclax for CLL	26
	26
Frail young adult cancer survivors experience poor health‐related quality of life	26
Cell‐free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls	26
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)	26
Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non‐Indigenous men in a universal health care system	26
A prospective, comprehensive registry that integrates the molecular analysis of pediatric and adolescent melanocytic lesions	25
The National Cancer Act of 1971: A seminal milestone in the fight against cancer	25
Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study	25
Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey	25
Adolescent and young adult cancer survivors are at increased risk for a second cancer	24
Oncologist affects integrative cancer care by writing songs with patients	24
Fertility preservation before and after cancer treatment in children, adolescents, and young adults	24
Heart failure linked with an increased risk of cancer	24
Issue Information	24
	24
What enhanced recovery means for patients with cancer undergoing surgery	24
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation	24
What if the age at which a woman started regular mammographic screening depended on her risk, not age?	24
Preventive strategies for breast cancer–related lymphedema: Working toward optimal patient selection	24
Associations between racial categories and outcomes suggest structural causes, not genetic advantages	23
	23
Potential of circulating tumor DNA to refine immunotherapy	23
Association of the m6A reader IGF2BP3 with tumor progression and brain‐specific metastasis in breast cancer	23
Attack of the clones: Unveiling subclonal/heterogenous mismatch repair/microsatellite instability status in endometrial cancer	23
SMAD4 loss predicts worse overall and distant metastasis‐free survival in patients with resected pancreatic adenocarcinoma	23
Issue Information	22
	22
Gut microbiome linked to aggressive prostate cancer	22
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality	22
Pathfinders in oncology from the time the causal relation between tobacco use and lung cancer was established to publication of the first Cancer Staging Manual by the American Joint Committee on Cance	22
Data‐driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer	22
The important role of nighttime compression in breast cancer–related lymphedema treatment	22
Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population	21
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation	21
Improving colorectal cancer screening by providing options	21
Reply to Air pollution was high centuries before industrial revolutions and may have been responsible for cancer rates in medieval Britain	21
Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort	21
Volume standards and outcomes measurement—Complementary strategies to improve surgical quality	21
ASCO releases equity, diversity, and inclusion action plan	20
Higher severity and risk of in‐hospital mortality for COVID‐19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data	20
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall	20
Anticancer therapies increase thromboembolic risk in hospitalized patients with cancer and COVID‐19	20
FDA approves new combined treatment for advanced prostate cancer	20
Updated American Cancer Society lung cancer screening guidelines	20
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma	20
The effects of curative‐intent cancer therapy on employment, work ability, and work limitations	20
Prevalence and predictors of cancer‐related worry and associations with health behaviors in adult survivors of childhood cancer	20
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort stu	20
Cocooning against COVID‐19: The argument for vaccinating caregivers of patients with cancer	20
Routine estradiol testing recommended for women at high risk of breast cancer	20
Issue Information	20
Outcome of Philadelphia chromosome‐positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019	19
Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VIS	19
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries	19
Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update	19
Sex‐based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children’s Oncology Group report	19
Association between prediagnostic prostate‐specific antigen and prostate cancer probability in Black and non‐Hispanic White men	19
A nomogram for predicting axillary node pathologic complete response—A necessary component of the path toward true axillary de‐escalation but needs a clear definition of the research question and a ro	19
Transplantation for myeloid neoplasms with antecedent solid tumor	19
A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma	19

Health insurance literacy among patients receiving outpatient cancer treatment	19
Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study	19
In pursuit of equity in cancer care: Moving beyond the Affordable Care Act	19
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer	18
Implementation, enrollment, and engagement in an opt‐out telehealth pharmacist‐assisted tobacco treatment program for patients seen in oncology outpatient clinics	18
	18
Critical insights into the evolving drug‐approval process in China	18
Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer	18
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer	18
	18
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade	18
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features	18
Thank You to Reviewers 2023	18
Virtual reality for pain management in hospitalized patients with cancer: A randomized controlled trial	18
Reply to “Metformin as a booster or obstacle of immunotherapy in patients with non–small cell lung cancer and diabetes mellitus”	18
New test for detecting cervical adenocarcinoma	18
Breast screening participation and degree of spread of invasive breast cancer at diagnosis in mental health service users: A population linkage study	18
An invisible population: Late‐stage cancer diagnosis for people with intellectual or developmental disability	18
Training oncology care providers in the assessment and treatment of tobacco use and dependence	17
Children and adolescents with hematologic cancers deserve better end‐of‐life care	17
Prediction models for breast cancer prognosis among Asian women	17
Brain–computer interface relieves chronic chemotherapy‐induced peripheral neuropathy: A randomized, double‐blind, placebo‐controlled trial	17
Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population‐based cohort study in Taiwan	17
Chemoimmunotherapy in patients with extensive‐stage small cell lung cancer and a poor performance status	17
Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system	17
The importance of the person/patient/survivor's lived experience across the cancer control continuum	17
Evaluating the sustainability of patient navigation programs in oncology by length of existence, funding, and payment model participation	17
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis	16
The American Cancer Society and patient navigation: Past and future perspectives	16
Time to cancer treatment and reproductive outcomes after fertility preservation among adolescent and young adult women with cancer	16
	16
Top advances of the year: Pediatric oncology	16
Role of primary care in opioid prescribing for older head and neck cancer survivors	16
Issue Information	16
Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer	16
Breast arterial calcification is a risk factor for cardiovascular disease	16
The economics of advanced and unresectable hepatocellular carcinoma	16
Reply to “Micro‐ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI‐RADS 3 lesions”	16
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people	16
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls	16
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?	16
Patients with completely resected nongenitourinary low‐risk embryonal rhabdomyosarcoma are candidates for reduced duration low‐intensity chemotherapy	16
Issue Information	16
Myeloma, melphalan, and the taste of transplantation	16
Yale study finds Black patients are more likely to experience uterine cancer testing delays	16
Patients with glioblastoma: A tale of health care access and genetic ancestry	16
Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers	15
Top advances of the year: Cervical cancer	15
	15
Annual report to the nation on the status of cancer	15
Issue Information	15
Top advances of the year: Myeloproliferative neoplasms	15
	15
Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies	15
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents	15
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas	15
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients	15
Issue Information	15
Race‐inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?	15
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenou	15
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana	15
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma	15
Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt	15
Patient navigation to address sociolegal barriers for patients with cancer: A comparative‐effectiveness study	15
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1	15
FDA center issues new guidelines, approves drugs	15
Issue Information	15
Global cancer statistics 2022	15
Falls prechemotherapy and toxicity‐related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial	14
Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data	14
Association of polypharmacy and potential drug‐drug interactions with adverse treatment outcomes in older adults with advanced cancer	14
Atezolizumab plus bevacizumab versus nivolumab as first‐line treatment for advanced or unresectable hepatocellular carcinoma: A cost‐effectiveness analysis	14
Antiprogrammed death ligand 1 therapy failed to reduce the risk of developing brain metastases in patients with extensive‐stage small cell lung cancer: A retrospective analysis	14
Evolving concepts in meningioma management in the era of genomics	14
The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival	14
Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database	14
Establishing a health profession: What oncology patient navigators can learn from the National Association of Community Health Workers	14
Dispositional hope as a potential outcome parameter among patients with advanced malignancy: An analysis of the ENABLE database	14
Female breast cancer most commonly diagnosed cancer globally	14
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor	14
Occupational exposures and risk of nasopharyngeal carcinoma in a high‐risk area: A population‐based case‐control study	14
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study	14
Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?	14
Active Living After Cancer: Adaptation and evaluation of a community‐based physical activity program for minority and medically underserved breast cancer survivors	14
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer	14
Immunotherapy for metastatic non–small cell lung cancer: Is it really a no‐brainer?	14
Exemptions to state laws regulating opioid prescribing for patients with cancer‐related pain: A summary	13
Clinical and genetic risk factors for radiation‐associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort	13
Adherence to hormonal therapy after surgery among older women with ductal carcinoma in situ: Implications for breast cancer–related adverse health events	13
Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women’s Health Initiative	13
Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer	13
Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study	13
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer	13
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status	13
Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies	13